CMC Analytical Development CDMOs in United States
95 published
95 published CDMOs match CMC Analytical Development in United States.
Locations in this set include United States, United Kingdom, China, Germany, Japan, and India.
Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Biologics (Monoclonal Antibodies), Gene Therapy, and Peptide.
Matching companies
BachemGlobal leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale.
Bend BioscienceU.S. pharmaceutical CDMO offering design, development, and manufacturing of oral solid and liquid dosage forms, from early formulation to commercial-scale production across three domestic locations.
Biopharma Technology LLCUSA-based CDMO specializing in lyophilization R&D, formulation development, and small-batch manufacturing for pharma and diagnostics. ISO 13485 and ISO 9001 certified with 35+ years of industry experience.
Boston Institute of Biotechnology, LLCFull-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L.
Bravado PharmaceuticalsBravado Pharmaceuticals is a Lutz, Florida pharmaceutical development company offering formulation development, analytical testing, and early-phase clinical manufacturing for client programs. It works across oral solid, injectable, and other dosage forms.
CMC Pharmaceuticals, Inc.CMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.- CRAMSNCRAMSN is a contract research, development, and manufacturing organization (CRO/CDMO/CMO) offering end-to-end solutions for drug substance and drug product development with GMP-certified facilities recognized by US, EU, Japan, and Canada regulatory authorities.
CambrexCDMO offering drug substance and drug product development, manufacturing, and analytical services across small molecules, peptides, and specialty chemistries.
Capitol BiologicsCapitol Biologics is a full-service CDMO supporting R&D and early-phase clinical trial manufacturing for emerging biotech firms. It focuses on biologics, proteins, and monoclonal antibodies from cell line development through GMP manufacturing.
CatalentGlobal CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.
CellaresCellares operates a global network of Smart Factories delivering integrated development and manufacturing (IDMO) services for cell therapies, with proprietary Cell Shuttle® and Cell Q™ platforms enabling cGMP-compliant, automated manufacturing and quality control at clinical and commercial scale.
Cellipont BioservicesCellipont Bioservices is a cell therapy CDMO offering end-to-end development, analytical, and cGMP manufacturing services for autologous, allogeneic, CAR-T, and iPSC-derived therapies from preclinical through commercial stages.
Charles River LaboratoriesCharles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
ClearsynthClearsynth delivers advanced deuterium science, isotopically labelled compounds, custom synthesis, and specialized CDMO services for small-molecule drug discovery and development. ISO 17025, ISO 17034, and ISO 9001:2015 certified with capabilities spanning reference standards, generic APIs, process development, and scale-up manufacturing.
CodisGlobal CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities.
Creative BiolabsCreative Biolabs provides custom recombinant antibody production, high-throughput antibody screening, GMP antibody manufacturing, and antibody biosimilar development services for biomedical research and therapeutic development.
CuriRx, Inc.CuriRx, Inc. is a Wilmington, Massachusetts contract research and development organization. It offers formulation development, prefilled syringe and lyophilization services, bioprocessing, and analytical testing to pharmaceutical companies of all sizes.
CuriaGlobal CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India.
Cytovance BiologicsU.S.-based CDMO offering end-to-end biomanufacturing services for antibodies, recombinant proteins, vaccines, and other biologics modalities, with dedicated microbial and mammalian facilities and in-house cell line development capabilities.
DipharmaGlobal CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.
Markdown mirror: /services/cmc-analytical-development/us.md